We are live on ! Find out more
BSX icon

Boston Scientific

457 hedge funds and large institutions have $15.3B invested in Boston Scientific in 2014 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 135 increasing their positions, 169 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $31.9M | Put options by funds: $19.1M

56% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 41

4% more funds holding

Funds holding: 439457 (+18)

3.02% more ownership

Funds ownership: 87.65%90.67% (+3%)

2% less capital invested

Capital invested by funds: $15.7B → $15.3B (-$346M)

20% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 169

46% less funds holding in top 10

Funds holding in top 10: 137 (-6)

Holders
457
Holders Change
+18
Holders Change %
+4.1%
% of All Funds
13.14%
Holding in Top 10
7
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-46.15%
% of All Funds
0.2%
New
64
Increased
135
Reduced
169
Closed
41
Calls
$31.9M
Puts
$19.1M
Net Calls
+$12.8M
Net Calls Change
-$22.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Boston Partners
26
Boston Partners
Massachusetts
$101M +$5.07M +389,545 +5%
Adage Capital Partners
27
Adage Capital Partners
Massachusetts
$94.8M +$4.46M +343,000 +5%
CLG
28
Cooperman Leon G
$83.6M -$25.8M -1,983,620 -23%
Los Angeles Capital Management
29
Los Angeles Capital Management
California
$81.8M -$5.47M -420,581 -6%
TCM
30
TimesSquare Capital Management
New York
$81.7M -$6.75M -519,000 -7%
Goldman Sachs
31
Goldman Sachs
New York
$81.4M +$5.05M +388,440 +6%
American Century Companies
32
American Century Companies
Missouri
$80.2M +$6.12M +470,838 +8%
Legal & General Group
33
Legal & General Group
United Kingdom
$78.1M +$585K +44,973 +0.7%
TCIM
34
TIAA CREF Investment Management
New York
$76.7M -$12.7M -972,934 -14%
PAM
35
Panagora Asset Management
Massachusetts
$72.2M +$9.04M +695,270 +14%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$71.7M +$13.5M +1,035,164 +23%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$68.3M -$1.53M -117,520 -2%
NTC
38
North Tide Capital
Massachusetts
$63.9M +$44.2M +3,400,000 +213%
TA
39
Teachers Advisors
New York
$62.8M -$175K -13,484 -0.3%
Two Sigma Investments
40
Two Sigma Investments
New York
$58.7M +$59.4M +4,568,712 +15,692%
UBS AM
41
UBS AM
Illinois
$57M +$1.18M +90,923 +2%
Axa
42
Axa
France
$56.1M +$57.1M +4,394,250 New
ACA
43
Anchor Capital Advisors
Massachusetts
$55.2M -$1.86M -142,827 -3%
Charles Schwab
44
Charles Schwab
California
$53.6M -$5.55M -427,138 -9%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$53.2M +$3.83M +294,328 +8%
Allianz Asset Management
46
Allianz Asset Management
Germany
$51.3M +$34.8M +2,673,570 +199%
BA
47
BlackRock Advisors
Delaware
$50.6M -$20.1M -1,546,935 -28%
Wells Fargo
48
Wells Fargo
California
$50.4M -$183M -14,045,198 -78%
Prudential Financial
49
Prudential Financial
New Jersey
$50.1M +$18.6M +1,433,434 +57%
Sumitomo Mitsui Trust Group
50
Sumitomo Mitsui Trust Group
Japan
$48.9M +$3.15M +242,077 +7%

BSX Hedge Fund Activity: Q2 2014 in Review

457 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2014, worth a combined $15.3B — down 2.2% from $15.7B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new BSX positions and 41 closed out — a net gain of 23 holders — while 135 added to existing stakes and 169 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $657M. The largest seller was Fidelity Investments, cutting an estimated $491M.

  • 457 institutional investors held Boston Scientific (BSX) as of Q2 2014, up from 439 in Q1 2014.
  • Funds reported $15.3B of Boston Scientific stock for Q2 2014, down 2.2% quarter-over-quarter.
  • 64 funds opened new Boston Scientific positions in Q2 2014 and 41 closed out, a net change of +23 holders.
  • The largest Boston Scientific buyer in Q2 2014 was JP Morgan Chase, an estimated $657M added.
  • The largest Boston Scientific seller in Q2 2014 was Fidelity Investments, an estimated $491M sold.

Based on aggregated 13F filings for Q2 2014.